Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Corynebacterium Infections | 3 | 2019 | 26 | 2.18 | Why? |
Corynebacterium diphtheriae | 5 | 2019 | 19 | 1.88 | Why? |
Diphtheria | 4 | 2019 | 74 | 1.53 | Why? |
Corynebacterium | 3 | 2019 | 47 | 1.48 | Why? |
Diphtheria Toxin | 2 | 2019 | 9 | 0.99 | Why? |
Salmonella Infections | 2 | 2019 | 82 | 0.88 | Why? |
Salmonella enterica | 1 | 2019 | 39 | 0.78 | Why? |
Borrelia | 4 | 2019 | 39 | 0.76 | Why? |
Hedgehogs | 1 | 2019 | 56 | 0.76 | Why? |
Mandatory Testing | 1 | 2018 | 67 | 0.70 | Why? |
Nasopharyngeal Diseases | 1 | 2017 | 44 | 0.67 | Why? |
Germany | 18 | 2021 | 9196 | 0.67 | Why? |
Whole Genome Sequencing | 5 | 2021 | 3239 | 0.61 | Why? |
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3633 | 0.50 | Why? |
Influenza A Virus, H3N2 Subtype | 1 | 2017 | 572 | 0.50 | Why? |
Sexually Transmitted Diseases, Bacterial | 1 | 2012 | 26 | 0.48 | Why? |
Genome, Bacterial | 4 | 2018 | 446 | 0.45 | Why? |
Multilocus Sequence Typing | 3 | 2019 | 264 | 0.39 | Why? |
Borrelia burgdorferi Group | 2 | 2018 | 12 | 0.38 | Why? |
Ixodes | 2 | 2019 | 58 | 0.36 | Why? |
Refugees | 1 | 2018 | 809 | 0.35 | Why? |
Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.34 | Why? |
Real-Time Polymerase Chain Reaction | 6 | 2021 | 11367 | 0.31 | Why? |
Birds | 2 | 2019 | 412 | 0.31 | Why? |
Carrier State | 1 | 2017 | 2100 | 0.29 | Why? |
Communicable Diseases | 1 | 2018 | 2148 | 0.25 | Why? |
Sexual Behavior | 1 | 2012 | 1322 | 0.24 | Why? |
Polymorphism, Single Nucleotide | 4 | 2019 | 3607 | 0.23 | Why? |
Bacterial Typing Techniques | 2 | 2019 | 273 | 0.21 | Why? |
Diagnostic Equipment | 1 | 2020 | 41 | 0.21 | Why? |
DNA, Bacterial | 3 | 2019 | 835 | 0.20 | Why? |
Turtles | 1 | 2019 | 17 | 0.20 | Why? |
Diphtheria Toxoid | 1 | 2019 | 6 | 0.20 | Why? |
Clavulanic Acid | 1 | 2019 | 20 | 0.20 | Why? |
Somalia | 1 | 2019 | 62 | 0.19 | Why? |
Disease Outbreaks | 5 | 2021 | 27595 | 0.19 | Why? |
Animal Feed | 1 | 2019 | 72 | 0.19 | Why? |
Bacteriophage Typing | 1 | 2017 | 1 | 0.19 | Why? |
Nasopharynx | 2 | 2021 | 10224 | 0.19 | Why? |
Salmonella enteritidis | 1 | 2017 | 10 | 0.18 | Why? |
Salmonella Food Poisoning | 1 | 2017 | 13 | 0.18 | Why? |
Oligonucleotide Array Sequence Analysis | 1 | 2020 | 343 | 0.18 | Why? |
Europe, Eastern | 1 | 2018 | 88 | 0.18 | Why? |
Food Microbiology | 1 | 2019 | 114 | 0.18 | Why? |
Amoxicillin | 1 | 2019 | 98 | 0.18 | Why? |
Pertussis Vaccine | 1 | 2019 | 89 | 0.18 | Why? |
Corynebacterium pseudotuberculosis | 1 | 2017 | 3 | 0.18 | Why? |
Eggs | 1 | 2017 | 43 | 0.18 | Why? |
Spices | 1 | 2019 | 130 | 0.18 | Why? |
Borrelia burgdorferi | 1 | 2017 | 31 | 0.17 | Why? |
Mass Screening | 1 | 2018 | 8005 | 0.17 | Why? |
Tea | 1 | 2019 | 126 | 0.17 | Why? |
Siblings | 1 | 2019 | 226 | 0.17 | Why? |
Plasmids | 2 | 2017 | 840 | 0.16 | Why? |
Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.16 | Why? |
Serogroup | 1 | 2019 | 510 | 0.16 | Why? |
Ticks | 1 | 2017 | 107 | 0.16 | Why? |
Phylogeny | 4 | 2019 | 13341 | 0.16 | Why? |
Influenza, Human | 2 | 2017 | 10779 | 0.14 | Why? |
Cattle | 1 | 2019 | 1336 | 0.14 | Why? |
Chickens | 1 | 2019 | 1010 | 0.13 | Why? |
DNA | 1 | 2019 | 778 | 0.13 | Why? |
Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
Communicable Diseases, Imported | 1 | 2020 | 843 | 0.11 | Why? |
Animals, Wild | 1 | 2019 | 1028 | 0.11 | Why? |
History, 21st Century | 1 | 2018 | 1849 | 0.11 | Why? |
Asia | 1 | 2018 | 2399 | 0.11 | Why? |
Workflow | 1 | 2020 | 2373 | 0.10 | Why? |
Bacterial Proteins | 1 | 2019 | 1318 | 0.10 | Why? |
Animals | 11 | 2021 | 78931 | 0.10 | Why? |
Disease Reservoirs | 1 | 2019 | 1672 | 0.10 | Why? |
Africa | 1 | 2018 | 2986 | 0.09 | Why? |
Viral Envelope Proteins | 1 | 2020 | 3539 | 0.08 | Why? |
Dietary Supplements | 1 | 2019 | 2251 | 0.08 | Why? |
Travel | 3 | 2021 | 7220 | 0.08 | Why? |
Humans | 25 | 2021 | 930598 | 0.08 | Why? |
France | 2 | 2019 | 12074 | 0.07 | Why? |
Transients and Migrants | 1 | 2018 | 1468 | 0.07 | Why? |
Genomics | 1 | 2017 | 3118 | 0.07 | Why? |
Sensitivity and Specificity | 3 | 2021 | 22971 | 0.07 | Why? |
RNA, Viral | 6 | 2021 | 32276 | 0.07 | Why? |
Public Health Surveillance | 1 | 2018 | 3129 | 0.07 | Why? |
Virus Shedding | 1 | 2021 | 5834 | 0.07 | Why? |
Child | 5 | 2021 | 70012 | 0.07 | Why? |
Species Specificity | 2 | 2019 | 1356 | 0.07 | Why? |
Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.07 | Why? |
Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
Multiplex Polymerase Chain Reaction | 2 | 2021 | 1439 | 0.06 | Why? |
Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
Infant | 3 | 2021 | 30274 | 0.06 | Why? |
Male | 7 | 2021 | 367725 | 0.05 | Why? |
Child, Preschool | 3 | 2021 | 36283 | 0.05 | Why? |
Retirement | 1 | 2021 | 157 | 0.05 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2021 | 13720 | 0.05 | Why? |
Nymph | 1 | 2019 | 11 | 0.05 | Why? |
Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
Ixodidae | 1 | 2019 | 37 | 0.05 | Why? |
Pneumonia, Viral | 4 | 2020 | 243684 | 0.05 | Why? |
Genome, Viral | 2 | 2021 | 13157 | 0.05 | Why? |
Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
Cross-Linking Reagents | 1 | 2019 | 91 | 0.05 | Why? |
Host-Parasite Interactions | 1 | 2019 | 112 | 0.05 | Why? |
Pneumonia | 1 | 2019 | 5652 | 0.05 | Why? |
Formaldehyde | 1 | 2019 | 135 | 0.05 | Why? |
Chromosomes, Bacterial | 1 | 2017 | 18 | 0.04 | Why? |
Luxembourg | 1 | 2017 | 125 | 0.04 | Why? |
Bacterial Infections | 1 | 2011 | 2229 | 0.04 | Why? |
Cytoplasm | 1 | 2019 | 304 | 0.04 | Why? |
Base Composition | 1 | 2017 | 203 | 0.04 | Why? |
Reverse Transcription | 1 | 2020 | 673 | 0.04 | Why? |
Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
Czech Republic | 1 | 2017 | 307 | 0.04 | Why? |
Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
Infant, Newborn | 1 | 2018 | 23105 | 0.04 | Why? |
Genes, Bacterial | 1 | 2017 | 207 | 0.04 | Why? |
In Vitro Techniques | 1 | 2019 | 1027 | 0.04 | Why? |
Female | 5 | 2021 | 380317 | 0.04 | Why? |
Antibodies, Bacterial | 1 | 2019 | 510 | 0.04 | Why? |
Genes, Viral | 1 | 2020 | 1428 | 0.04 | Why? |
Population Surveillance | 1 | 2011 | 4967 | 0.03 | Why? |
Cats | 1 | 2021 | 1890 | 0.03 | Why? |
Molecular Diagnostic Techniques | 2 | 2021 | 4239 | 0.03 | Why? |
Adolescent | 3 | 2021 | 86841 | 0.03 | Why? |
RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.03 | Why? |
Sentinel Surveillance | 1 | 2021 | 1093 | 0.03 | Why? |
Young Adult | 3 | 2021 | 93724 | 0.03 | Why? |
Mass Spectrometry | 1 | 2019 | 1165 | 0.03 | Why? |
Austria | 1 | 2017 | 1259 | 0.03 | Why? |
Sputum | 1 | 2021 | 1720 | 0.03 | Why? |
Aged | 3 | 2021 | 215776 | 0.03 | Why? |
Greece | 1 | 2019 | 2091 | 0.03 | Why? |
Treatment Outcome | 1 | 2019 | 51732 | 0.03 | Why? |
Adult | 4 | 2021 | 244371 | 0.03 | Why? |
Vaccination | 2 | 2019 | 19050 | 0.03 | Why? |
Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
Interviews as Topic | 1 | 2020 | 1952 | 0.03 | Why? |
California | 1 | 2017 | 2047 | 0.03 | Why? |
Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.03 | Why? |
Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
Turkey | 1 | 2019 | 3937 | 0.02 | Why? |
Seasons | 1 | 2021 | 4071 | 0.02 | Why? |
Proteomics | 1 | 2019 | 2481 | 0.02 | Why? |
Laboratories | 1 | 2020 | 2858 | 0.02 | Why? |
Point-of-Care Systems | 1 | 2020 | 2955 | 0.02 | Why? |
Aged, 80 and over | 1 | 2017 | 88759 | 0.02 | Why? |
Feces | 1 | 2020 | 4235 | 0.02 | Why? |
Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.02 | Why? |
Middle Aged | 3 | 2021 | 270681 | 0.02 | Why? |
Schools | 1 | 2021 | 4187 | 0.02 | Why? |
Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
Evolution, Molecular | 1 | 2017 | 3691 | 0.02 | Why? |
Europe | 1 | 2019 | 12702 | 0.01 | Why? |
Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
China | 1 | 2020 | 50654 | 0.01 | Why? |
Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
Prevalence | 1 | 2011 | 25773 | 0.01 | Why? |
Sing's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(126)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_